Global Epilepsy Monitoring Devices Market to be Propelled by Rise of Road Accidents and Brain Injuries by CAGR of ~5% During 2023 – 2033
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc.
Research Nester published a report titled “Epilepsy Monitoring DevicesMarket: Global Demand Analysis & Opportunity Outlook 2033” which delivers detailed overview of the global epilepsy monitoring devices market in terms of market segmentation by product, by technology, by epilepsy detection & prediction devices, by end-user, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global epilepsy monitoring devices market is estimated to grow with a CAGR of ~5% over the forecast period, i.e., 2023 – 2033. The market is segmented by end-user into hospitals & clinics and home care settings. Among these, the hospitals & clinicssegment is expected to hold a notable share in the market owing to the rise in government investment in the healthcare sector to improve hospitals and clinics. In 2020, the national health expenditure grew from 9.7% to 4.1 trillion, as per estimations.
The global epilepsy monitoring devices market is anticipated to garner a revenue of ~USD 620 Million by the end of 2033, from revenue of ~USD 489 Million in the year 2022. The market is expected to grow on account of a rise in the adoption of advanced treatment techniques by people and an increase in related reimbursement policies during the forecast period. Over USD 400 billion is estimated to save up to 10% of health care expenditure with the newly proposed Medicare for All Act (MAA) of American healthcare expenditure.
Request Report Sample@ https://www.researchnester.com/sample-request-4375
Geographically, the global epilepsy monitoring devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Out of which the market in the Europe region is projected to hold the highest market share during the forecast period on the back of rising road accidents and sports around the region. About 19,000 deaths are reported by road crashes in Europe in 2021.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Increasing Number of Epilepsy and Seizures Cases to Drive the Market Growth
In the U.S more than 1% of the population suffered from epilepsy as of 2021.
The manufacturers are more focused on epilepsy monitoring devices to decrease the number of cases and death rate of epilepsy and seizures. The devices assist in reducing, preventing, detecting and monitoring the progression of epilepsy disorders.
However, a lack of knowledge about medical devices and diagnostic challenges are expected to operate as key restraints to the growth of epilepsy monitoring devices market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global epilepsy monitoring devices market which includes company profiling of Natus Medical Incorporated, Compumedics Limited, Empatica Inc., Magstim, Inc., Nihon Kohden Corporation, Medtronic Plc, Boston Scientific Corporation, Masimo Corporation, Drägerwerk AG & Co. KGaA, and Abbott Laboratories. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global epilepsy monitoring devices market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Consult Our Expert Analysts@
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919